Search Results - "Nieuweboer, A"

The influence of prior novel androgen receptor targeted therapy on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancer by van Soest, R.J, Nieuweboer, A.J.M, de Morrée, E.S, Chitu, D, Bergman, A.M, Goey, S.H, Bos, M.M, van der Meer, N, Hamberg, P, de Wit, R, Mathijssen, R.H.J

“…Abstract Introduction The treatment armamentarium for metastatic castration-resistant prostate cancer (mCRPC) has expanded with the introduction of several new…”
Get full text

The Intracellularly Acting Effector Foa3 Suppresses Defense Responses When Infiltrated Into the Apoplast by Tintor, Nico, Nieuweboer, Gea A M, Bakker, Ilse A W, Takken, Frank L W

“…Plant pathogens employ secreted proteins, among which are effectors, to manipulate and colonize their hosts. A large fraction of effectors is translocated into…”
Get full text

Role of genetic variation in docetaxel-induced neutropenia and pharmacokinetics by Nieuweboer, A J M, Smid, M, de Graan, A-J M, Elbouazzaoui, S, de Bruijn, P, Eskens, F A L M, Hamberg, P, Martens, J W M, Sparreboom, A, de Wit, R, van Schaik, R H N, Mathijssen, R H J

“…Docetaxel is used for treatment of several solid malignancies. In this study, we aimed for predicting docetaxel clearance and docetaxel-induced neutropenia by…”
Get full text

2564 The influence of prior novel androgen receptor targeted therapy on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancer by Van Soest, R, Nieuweboer, A, De Morrée, E, Chitu, D, Bergman, A, Goey, H, Bos, M, Van der Meer, N, Hamberg, P, De Wit, R, Mathijssen, R

Get full text

2575 Presence of androgen receptor splice variants in circulating tumor cells and response to cabazitaxel in castration-resistant prostate cancer by Onstenk, W, Sieuwerts, A, Kraan, J, Van, M, Nieuweboer, A, Mathijssen, R, Hamberg, P, Meulenbeld, H, DeLaere, B, Dirix, L, Van Soest, R, Lolkema, M, Martens, J, Van Weerden, W, Jenster, G, Foekens, J, De Wit, R, Sleijfer, S

Get full text

784PPHARMACOKINETIC (PK) ACTIVITY OF CABAZITAXEL (CBZ) IN PATIENTS (PTS) WITH RENAL IMPAIRMENT (RI) by Azaro, A., Rodon, J., Machiels, J., Rottey, S., Damian, S., Baird, R., Nieuweboer, A., Clot, P., Wack, C., Shen, L., Bobilev, D., De Jonge, M.

“…Abstract Aim: Limited data are available on Cbz PK in pts with RI (14 with moderate RI, 1 with severe RI [Ferron, Cancer Chemother Pharmacol 2013]). This…”
Get full text

Pharmacokinetic (Pk) Activity of Cabazitaxel (Cbz) in Patients (Pts) with Renal Impairment (Ri) by Azaro, A., Rodon, J., Machiels, J., Rottey, S., Damian, S., Baird, R., Nieuweboer, A., Clot, P., Wack, C., Shen, L., Bobilev, D., De Jonge, M.

Get full text

Increased Clearance of Docetaxel in Androgen Deprived Prostate Cancer Patients by Nieuweboer, A. J. M., de Graan, A. J., de Jonge, M. J. A., de Bruijn, P., Friberg, Lena E., van Doom, L., Wiemer, E. A. C., de Wit, R., Mathijssen, R. H.

Get full text